[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100419707":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":24,"responsibleParty":44,"collaborators":18,"id":48,"slug":18,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":18,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":18,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":18,"overallStatus":27,"whyStopped":18,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"The First Affiliated Hospital of Soochow University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"with auto-FMT","EXPERIMENTAL","The patients in the experimental group took autologous fecal bacteria capsule about 3 weeks after bone marrow transplantation.",[13],"Other: autologous fecal bacteria",{"label":15,"type":16,"description":17,"interventionNames":18},"empty capsule","NO_INTERVENTION","The patients in this group took empty capsule about 3 weeks after bone marrow transplantation",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"autologous fecal bacteria","autologous fecal bacteria transplantation",[9],[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Ye Zhao","RECRUITING","Suzhou","Jiangsu","215006","China","CN",{"type":34,"coordinates":35},"Point",[36,37],120.59538,31.30408,{"lat":37,"lon":36},[40],{"name":26,"role":41,"phone":42,"phoneExt":18,"email":43},"CONTACT","+8651267780410","mutation@163.com",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Qi Xiao-Fei","Principal Investigator","100419707",false,"NCT04745221","Efficacy and Safety of Auto-FMT in Preventing aGVHD","Efficacy and Safety of Autologous Fecal Bacteria Transplantation in Preventing Acute Graft Versus Host Disease After Haploidentical Hematopoietic Stem Cell Transplantation: a Multicenter, Open, Randomized Controlled Clinical Study","Inclusion Criteria:\n\n* Haplo-HSCT patients; Bacteroidetes \\>0.1%; inverse Simpson diversity ≥2\n\nExclusion Criteria:\n\n* Gastrointestinal diseases；Age\\>60; or Age\\\u003C10；Probiotics or prebiotics were taken before enrollment","ALL","18 Years","60 Years",{"count":58,"type":59},100,"ESTIMATED","INTERVENTIONAL",[62],"NA","To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.",[65],"Graft Versus Host Disease, Acute","2026-05-28",{"date":68,"type":69},"2026-06-01","ACTUAL",{"date":71,"type":69},"2021-03-01",{"date":73,"type":59},"2027-03-01",{"name":5,"class":6},1]